The U.S. Food and Drug Administration (FDA) has called for the removal of several acne treatment products from store shelves after testing revealed slightly elevated levels of benzene, a chemical linked to cancer.
The recall affects six benzoyl peroxide-based products, including Walgreens Acne Control Cleanser, Proactiv Skin Smoothing Exfoliator, and La Roche-Posay Effaclar Duo Dual Action Acne Treatment. The FDA released a full list of affected products and lot numbers online Tuesday.
Although the agency emphasized that the risk of developing cancer from these products remains low, even with long-term use, it has advised retailers to stop selling the affected items as a precautionary measure.
Concerns Over Benzene Exposure
Benzene is a chemical found in crude oil, gasoline, and cigarette smoke. Prolonged exposure to high levels has been linked to leukemia and other serious illnesses. However, the FDA reassured consumers that the levels detected in the recalled products pose minimal health risks.
The agency began its investigation after private laboratory reports raised concerns about benzene contamination in acne treatments. FDA scientists tested 95 acne products before identifying six that exceeded acceptable benzene levels.
Broader Issue of Contamination
This is not the first time benzene contamination has led to recalls. In recent years, the chemical has been found in hand sanitizers, aerosol sprays, and sunscreens, prompting similar actions by the FDA.
While the current recall is limited to certain acne creams, the FDA continues to monitor other personal care products to ensure consumer safety.
What Consumers Should Do
Despite the recall, the FDA has not issued any specific recommendations for consumers who may have already purchased or used the affected products. However, those concerned about potential exposure may choose to discontinue use and consult with healthcare professionals for further guidance.
Retailers are expected to comply with the recall immediately, and the FDA will continue its investigations into potential contamination risks in other skincare and cosmetic products.
